Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Zinc Gluconate for Acne Vulgaris
NCT05096312Phase 4Completed
- Sponsor
- East Avenue Medical Center
- Start
- Dec 2018
- Primary completion
- Jul 2019
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by East Avenue Medical Center. Primary endpoints: Global Acne Grading System Score at 8 weeks and Inflammatory Score at 8 weeks. Started Dec 2018; status: completed.
Beyond the preview
Go deeper on NCT05096312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096312.